Elsawy, M. (2022). Chimeric antigen receptor T-cell therapy for relapsed and refractory large B-cell lymphoma: A Canadian perspective. Canadian Hematology Today, 1(2), 26–33. https://doi.org/10.58931/cht.2022.1214